CLN-418

· Harbour BioMed US, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CLN-418, covering 2025-04-25 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: CLN-418 Study on Subjects With Advanced Solid Tumors [Phase 1]